國際醫學研究碩博士學位學程

Medicine & Life Sciences

1. Adenocarcinoma of Lung 18%
2. Air Pollution 14%
3. Alzheimer Disease 12%
4. Apoptosis 45%
5. Atrial Fibrillation 18%
6. Autophagy 36%
7. Biomarkers 31%
8. Bipolar Disorder 20%
9. Blood Platelets 21%
10. Brain 14%
11. Breast Neoplasms 29%
12. Calcium 21%
13. Carcinoma 12%
14. Cardiac Myocytes 19%
15. Catenins 22%
16. Cell Movement 16%
17. Cell Proliferation 17%
18. Chronic Obstructive Pulmonary Disease 18%
19. Chronic Renal Insufficiency 32%
20. Cognitive Dysfunction 15%
21. Cohort Studies 26%
22. Collagen 13%
23. Colorectal Neoplasms 27%
24. Confidence Intervals 34%
25. Coronavirus 12%
26. Databases 18%
27. Datasets 15%
28. Dementia 19%
29. Depression 15%
30. Diabetes Mellitus 13%
31. Down-Regulation 29%
32. Drug Therapy 15%
33. Endothelial Cells 13%
34. Epigenomics 13%
35. Epithelial-Mesenchymal Transition 19%
36. ErbB Receptors 18%
37. Fibroblasts 20%
38. Fibrosis 14%
39. Gene Expression 17%
40. Genes 29%
41. Glioblastoma 33%
42. Glioma 22%
43. Growth 19%
44. Health Literacy 30%
45. Healthy Diet 13%
46. Hepatocellular Carcinoma 22%
47. Histone Deacetylases 13%
48. Homeostasis 16%
49. honokiol 13%
50. Hypoxia 12%
51. In Vitro Techniques 20%
52. Inflammation 16%
53. Kidney 23%
54. Lipopolysaccharides 13%
55. Lung 21%
56. Lung Neoplasms 32%
57. Machine Learning 22%
58. Medicine 15%
59. Messenger RNA 14%
60. Meta-Analysis 38%
61. MicroRNAs 13%
62. Mortality 16%
63. Mouth Neoplasms 15%
64. Mutation 15%
65. Nanoparticles 17%
66. Neoplasm Metastasis 34%
67. Neoplasms 55%
68. Neoplastic Stem Cells 22%
69. Non-Small Cell Lung Carcinoma 21%
70. Odds Ratio 25%
71. Ovarian Neoplasms 16%
72. Oxidative Stress 17%
73. Paclitaxel 12%
74. Parkinson Disease 19%
75. Particulate Matter 12%
76. Pharmaceutical Preparations 16%
77. Phosphorylation 18%
78. Phosphotransferases 12%
79. Platelet Activation 24%
80. Population 31%
81. Proteins 38%
82. Pulmonary Veins 25%
83. Reactive Oxygen Species 19%
84. Recurrence 12%
85. Renal Dialysis 21%
86. Retrospective Studies 12%
87. Serum 22%
88. Sinoatrial Node 12%
89. Small Interfering RNA 12%
90. Stroke 56%
91. Survival 18%
92. Systematic Reviews 26%
93. Taiwan 100%
94. Temozolomide 13%
95. Therapeutics 37%
96. Thrombosis 13%
97. Traumatic Brain Injury 15%
98. Triple Negative Breast Neoplasms 24%
99. Up-Regulation 23%
100. Wounds and Injuries 18%